ArticleJAMA network open2021

Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis.

Jue Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.